Ipele Ifihan Antibody Development Platform
Phage àpapọ Technology

Ipele Ifihan Antibody Production Workflow
Awọn igbesẹ | Akoonu Iṣẹ | Ago |
---|---|---|
Igbesẹ 1: Ajẹsara ẹranko | (1) Ajẹsara ẹranko ni igba mẹrin, ajẹsara ajẹsara 1 iwọn lilo, apapọ awọn abere 5 ti ajẹsara. (2) Omi ara odi ṣaaju ki o to gba ajesara, ati pe ELISA ti ṣe ni iwọn kẹrin lati ṣawari titer serum. (3) Ti o ba jẹ pe titer antibody omi ara ti iwọn kẹrin pade awọn ibeere, iwọn lilo afikun kan ti ajesara yoo jẹ abojuto ni ọjọ meje ṣaaju gbigba ẹjẹ. Ti ko ba pade awọn ibeere, ajesara igbagbogbo yoo tẹsiwaju. (4) Agbara ti o peye, gbigba ẹjẹ ati iyapa awọn monocytes | 10 ọsẹ |
Igbesẹ 2: Igbaradi cDNA | (1) PBMC Apapọ RNA isediwon (Apo isediwon RNA) (2) Igbaradi RT-PCR iduroṣinṣin giga ti cDNA (ohun elo transcription yiyipada) | 1 ọjọ |
Igbesẹ 3: Ikole Ile-ikawe Antibody | (1) Lilo cDNA gẹgẹbi awoṣe, awọn Jiini ti ni ilọsiwaju nipasẹ awọn iyipo meji ti PCR. (2) Ikole alakoso ati iyipada: jiini splicing phagemid fekito, iyipada electroporation ti TG1 ogun kokoro arun, ikole ti agboguntaisan ìkàwé. (3) Idanimọ: Laileto yan awọn ere ibeji 24, PCR idanimọ oṣuwọn rere + oṣuwọn ifibọ. (4) Iranlọwọ igbaradi phage: M13 phage ampilifaya + ìwẹnumọ. (5) Fage àpapọ ìkàwé giga | 3-4 ọsẹ |
Igbesẹ 4: Ṣiṣayẹwo Ile-ikawe Antibody (awọn iyipo mẹta) | (1) Aṣayẹwo 3-yika aiyipada (iṣayẹwo ipele-lile): Ṣiṣayẹwo titẹ lati yọkuro awọn apo-ara ti kii ṣe pato si iwọn ti o pọju ti o ṣeeṣe. (2) bacteriophage ampilifaya oniye ẹyọkan ti a ti yan + IPTG induced ikosile + wiwa ELISA ti awọn ere ibeji rere. (3) Gbogbo awọn ere ibeji rere ni a yan fun tito lẹsẹsẹ pupọ. | 4-5 ọsẹ |

Awọn iṣẹ atilẹyin
A le pese awọn iṣẹ ikole ile ikawe ti ajẹsara ti o yatọ si ẹranko ati awọn iṣẹ ibojuwo ile-ikawe antibody ni ibamu si awọn iwulo alabara

Multiple Àkọlé
Awọn iṣẹ iṣawari ipakokoro ibi-afẹde pupọ wa: awọn ọlọjẹ, awọn peptides, awọn ohun elo kekere, awọn ọlọjẹ, awọn ọlọjẹ awọ ara, mRNA, ati bẹbẹ lọ.

Multiple Vectors
Iṣẹ ikole ile-ikawe ti ara ẹni, a le pese ọpọlọpọ awọn onibajẹ bacteriophage pẹlu PMECS, pComb3X, ati pCANTAB 5E, ati yipada wọn ni ibamu si awọn iwulo alabara.

Ogbo Platform
Agbara ipamọ le de ọdọ 10 ^ 8-10 ^ 9, awọn oṣuwọn ifibọ gbogbo wa ju 90% lọ, ati ibaramu ti awọn apo-ara ti a gba nipasẹ ibojuwo ni gbogbogbo ni ipele nM pM
Monoclonal Antibody Development Service
A le pese didara to gaju, mimọ-giga, ati awọn iṣẹ idagbasoke apakokoro monoclonal kan pato, pẹlu iṣelọpọ ti awọn apo-ara monoclonal Asin ati awọn aporo monoclonal ehoro
Hybridoma Technology Platform
Pẹlu eto ajẹsara, awọn iṣẹ igbaradi agboguntaisan, isọdọmọ antibody, ipasẹ iṣelọpọ giga antibody, afọwọsi antibody, bbl
Nikan B Cell Yiyan Platform
Alpha Lifetech ni awọn anfani ni akoko ibojuwo ati gbigba awọn ọlọjẹ didara to gaju. O le pese apẹrẹ antijeni, kolapọ, ati iyipada, ajesara ẹranko, ibojuwo imudara sẹẹli B ẹyọkan, ṣiṣesẹsẹ sẹẹli kan.

Ipele Ifihan Antibody Development Platform
Alpha Lifetech le pese awọn iṣẹ imọ-ẹrọ idagbasoke apakokoro ifihan phage lati igbaradi agboguntaisan, iwẹnumọ agboguntaisan, tito nkan lẹsẹsẹ antibody, ati bẹbẹ lọ.